¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hereditary persistence of fetal hemoglobin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® hemoglobin ÇÑ±Û Ç÷»ö¼Ò
¼³¸í   
  Ã´Ãßµ¿¹°ÀÇ ÀûÇ÷±¸ ¼Ó¿¡ ´Ù·®À¸·Î µé¾îÀִ »ö¼Ò´Ü¹éÁú. Ã¶À» Ç°´Â Æ÷¸£ÇǸ° °í¸®¿Í ´Ü¹éÁúÀÇ ÀÏÁ¾(±Û·Îºó)À¸·Î µÇ¾î ÀÖ´Ù. Ã¶(Fe)¿¡´Â »ê¼Ò¿Í °¡¿ªÀûÀ¸·Î °áÇÕÇϴ ´É·ÂÀÌ ÀÖ¾î, »ýü ³»¿¡¼­´Â »ê¼Ò¸¦ ¿î¹ÝÇϴ ÀÏÀ» ÇÑ´Ù. Ç÷»ö¼Ò ÇÑ ºÐÀڴ ³× °³ÀÇ Æú¸®ÆéƼµå »ç½½·Î µÇ¾î ÀÖ°í, °¢°¢ÀÇ Æú¸®ÆéƼµå »ç½½¿¡´Â ÇÑ °³¾¿ÀÇ ÇðÀÌ ÇÔÀ¯µÇ¾î ÀÖ´Ù. µû¶ó¼­ Ç÷»ö¼Ò ÇÑ ºÐÀÚ¿¡´Â Ã¶¿øÀÚ°¡ ³× °³ ÇÔÀ¯µÇ°í, Ã¶¿øÀÚ ÇÑ °³¿¡ ´ëÇØ ÇÑ ºÐÀÚ¾¿ÀÇ »ê¼Ò°¡ °áÇÕÇϹǷÎ, Ç÷»ö¼Ò ÇÑ ºÐÀÚ¿¡´Â »ê¼Ò 4ºÐÀÚ°¡ °áÇÕÇÑ´Ù. Ç÷»ö¼Ò´Â »ê¼Ò¾ÐÀÌ ³ôÀº ÇãÆÄ³ª ¾Æ°¡¹Ì¿¡¼­´Â »ê¼Ò¿Í °áÇÕÇϰí, »ê¼Ò¾ÐÀÌ ³·Àº Á¶Á÷¿¡ À̸£¸é »ê¼Ò¸¦ À¯¸®ÇÑ´Ù. ´õ¿íÀÌ »ê¼ÒÀÇ ¹æÃâÀº pH°¡ ³·¾ÆÁü¿¡ µû¶ó ÃËÁøµÇ¹Ç·Î, ÀÌ»êȭź¼Ò°¡ ¸¹°í pH°¡ ³·Àº ¸»ÃÊÁ¶Á÷¿¡¼­´Â »ê¼Ò¸¦ º¸´Ù À¯¸®Çϱ⠽±°Ô µÈ´Ù. ÀÌ»êȭź¼Ò´Â Ç÷Àå ¼Ó¿¡ ³ì¾Æ ÇãÆÄ¿¡ ¿î¹ÝµÇ¾î ÇãÆÄÈ£ÈíÀ¸·Î Ã¼¿Ü¿¡ ¹æÃâµÇ¸é pH´Â ´Ù½Ã ¿ø»óÅ·Πµ¹¾Æ°¡°í Ç÷»ö¼Ò´Â ´Ù½Ã »ê¼Ò¿Í °áÇÕÇÑ´Ù. ºÐÀÚ·® ¾à 6,500ÀÇ »ö¼Ò´Ü¹éÁú·Î Ç÷¾× ¼Ó¿¡¼­ÀÇ ÇÔÀ¯·®Àº Ç÷¾× 100 mLÁßÀÇ ±×·¥¼ö·Î ³ªÅ¸³½´Ù. Á¤»óÄ¡´Â ³²ÀÚ 16g/dL(14~18g/dL), ¿©ÀÚ 14g/dL (12~16g/dL)ÀÌ´Ù.
¿µ¹® fetal monitoring ÇÑ±Û Å¾ư¨½Ã
¼³¸í   
  ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀǠžÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» Å¾ư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü Å¾ư¨½Ã¿Í ºÐ¸¸Áߠžư¨½Ã·Î Å©°Ô ³ª´«´Ù.
  
  1. ºÐ¸¸Àü Å¾ư¨½Ã´Â ºÐ¸¸Çϱâ ÀÌÀüÀǠžÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù.
  
    1)¾ç¼öõÀÚ-ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼­ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼­ ¾ç¼ö¸¦ ¾ò¾î¼­ ºÐ¼®ÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼­ ½Ç½ÃÇÒ ¼ö°¡ ÀÖ´Ù.
  
    2)ÅÈÁÙõÀÚ-ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼­ ÅÈÁÙ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼­ ±×°÷ÀÇ Ç÷°üÀ» Ã£¾Æ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»çÇϴ ¹æ¹ý.
  
    3)½ºÆ®·¹½º°Ë»ç-žƵµ Àڱüӿ¡¼­ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î Å¾ư¡ Àڱüӿ¡¼­ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â Å¾ÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. Å¾ÆÀÇ ¿îµ¿°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ Å¾ÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù.
  
    4)žÆÃ»°¢Àڱذ˻ç-30ÁÖ ÀÌ»óÀÌ µÈ Å¾ƴ ¼Ò¸®ÀÇ Àڱؿ¡ ´ëÇØ¼­ ¹ÝÀÀÀ» ÇÑ´Ù. Áï ¼Ò¸®¸¦ µé·ÁÁÖ¾úÀ» °æ¿ì¿¡ Å¾ư¡ ¹ÝÀÀÀ» Çؼ­ ½ÉÀåÀÇ ¹Úµ¿¼ö°¡ Áõ°¡¸¦ ÇÑ´Ù.
  
    5)¼öÃེƮ·¹½º°Ë»ç-Á¤»óÀûÀΠžƴ ÀÚ±ÃÀÌ ¼öÃàÇϸé ÀÌ¿¡ ¹ÝÀÀÀ» Çؼ­ ½É¹Ú¼ö°¡ º¯È­ÇÑ´Ù. À̰ÍÀ» ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀÌ´Ù.
  
  2. ºÐ¸¸Áߠžư¨½Ã
  
  ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ °Ç°­»óŸ¦ °¨½ÃÇϴ °ÍÀÌ´Ù. ´ëü·Î ºÐ¸¸µµÁß¿¡ Å¾ư¡ Àú»ê¼ÒÁõÀ̳ª ¿©·¯ °¡Áö Ãæ°ÝÀ» ¹Þ´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î ºÐ¸¸µµÁßÀǠžư¨½Ã´Â Áß¿äÇÑ Àǹ̸¦ °¡Áø´Ù.
  
    1)ÀüÀڽĞư¨½Ã-Àü±âÀû ÀåÄ¡¸¦ ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ¸·Î °¨½ÃÀÇ ´ë»óÀº ÀÚ±ÃÀÇ ¼öÃà°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿¼öÀÌ´Ù.
  
    2)žƸӸ®µ¤°³ Ç¥º»Ã¤Ãë Ç÷¾×-ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ µÎÇÇÀÇ Ç÷°ü¿¡¼­ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»ç¸¦ ÅëÇØ¼­ Å¾ÆÀÇ »óŸ¦ ¾Æ´Â ¹æ¹ýÀÌ´Ù. ÁַΠ°Ë»ç¸¦ ÇàÇϴ Á¾¸ñÀº Ç÷¾×ÀÇ pHÀÌ´Ù.
¿µ¹® fetal assessment ÇÑ±Û Å¾ƻçÁ¤
¼³¸í   
  ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀǠžÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» Å¾ư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü Å¾ư¨½Ã¿Í ºÐ¸¸Áߠžư¨½Ã·Î Å©°Ô ³ª´«´Ù. 1. ºÐ¸¸Àüžư¨½Ã: ºÐ¸¸Çϱâ ÀÌÀüÀǠžÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ¨ç ¾ç¼öõÀÚ: ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼­ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼­ ¾ç¼ö¸¦ ¾ò¾î¼­ ºÐ¼®ÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼­ ½Ç½ÃÇÒ ¼ö ÀÖ´Ù. ¨è ÅÈÁÙõÀÚ: ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼­ ÅÈÁÙ ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼­ ±× °÷ÀÇ Ç÷°üÀ» Ã£¾Æ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»çÇϴ ¹æ¹ý. ¾ÆÁÖ À§ÇèÇÒ °Í °°Áö¸¸ »ó´çÈ÷ ¾ÈÀüÇÑ °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. ´Ù¸¥ °Ë»ç¿¡ ºñÇØ¼­ °Ë»ç¿¡ ¸¹Àº ±â¼úÀÌ ÇÊ¿äÇÏÁö¸¸ ¾ÆÁÖ ¸¹Àº Á¤º¸¸¦ Á¦°øÇØ ÁØ´Ù. ¨é ºñ½ºÆ®·¹½º°Ë»ç(nonstress test) : Å¾Ƶµ Àڱà¼Ó¿¡¼­ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î Å¾ư¡ Àڱà¼Ó¿¡¼­ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â Å¾ÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. Å¾ÆÀÇ ¿îµ¿°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ Å¾ÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù.
¿µ¹® fetal alcohol syndrome ÇÑ±Û Å¾ƾËÄÚ¿ÃÁõÈıº
¼³¸í   
  ÀӽűⰣ Áß ¸¸¼ºÀûÀ¸·Î ¾ËÄÚ¿ÃÀ» ¼·ÃëÇÑ ¿©ÀÚ¿¡°Ô¼­ Å¾ ¿µ¾Æ¿¡°Ô ³ªÅ¸³ª´Â ÇüŹ߻ýÀÇ ÀÌ»óÀ» ³ªÅ¸³»´Â ÁõÈıºÀ¸·Î¼­ À§ÅλÀ¹ßÀ°ºÎÀü, ¾Õ¸Ó¸®¿Í ¾Æ·¡ÅÎÀÇ µ¹Ãâ, ÂªÀº°Ë¿­, ÀÛÀº¾È±¸Áõ, ´«±¸¼®ÁÖ¸§, ½ÉÇÑ ¼ºÀåÁö¿¬, Á¤½ÅÁöü µîÀ» ³ªÅ¸³½´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žÆÇ÷»ö¼Ò
  • persistent fetal hemoglobin
    Áö¼ÓžÆÇ÷»ö¼Ò
  • denatured hemoglobin
    º¯¼ºÇ÷»ö¼Ò
  • fast hemoglobin
    ±Þ¼ÓÇ÷»ö¼Ò
  • glycosylated hemoglobin
    ´çÈ­Çì¸ð±Û·Îºó
  • hemoglobin
    Ç÷»ö¼Ò, Çì¸ð±Û·Îºó
  • hemoglobin absorption curve
    Çì¸ð±Û·ÎºóÈí¼ö°î¼±
  • hemoglobin C
    Çì¸ð±Û·ÎºóC
  • hemoglobin C disease
    Çì¸ð±Û·ÎºóCº´
  • hemoglobin disease
    Çì¸ð±Û·Îºóº´, Ç÷»ö¼Òº´
  • hemoglobin E disease
    Çì¸ð±Û·ÎºóEº´
  • hemoglobin electrophoresis
    Ç÷»ö¼ÒÀü±âÀ̵¿, Çì¸ð±Û·ÎºóÀü±âÀ̵¿
  • hemoglobin F
    Çì¸ð±Û·ÎºóF
  • hemoglobin M disease
    Çì¸ð±Û·ÎºóMº´
  • hemoglobin oxygen saturation
    Çì¸ð±Û·Îºó»ê¼ÒÆ÷È­µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hemoglobin electrophoresis
    Ç÷»ö¼ÒÀü±âÀ̵¿, Ç÷»ö¼ÒÀü±â¿µµ¿
  • hemoglobin
    Ç÷»ö¼Ò
  • hereditary
    À¯Àü-
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò
  • hereditary motor sensory neuropathy
    À¯Àü¿îµ¿°¨°¢½Å°æº´Áõ
  • hereditary spherocytosis
    À¯ÀüµÕ±ÙÀûÇ÷±¸Áõ, À¯Àü±¸ÇüÀûÇ÷±¸Áõ
  • fetal anemia
    žƺóÇ÷
  • fetal head compression
    žƸӸ®¾Ð¹Ú
  • severe fetal distress
    ½ÉÇÑžÆÀý¹Ú°¡»ç, ½ÉÇÑžưíÅë
  • fetal
    žÆ-
  • fetal hypoxia
    žÆÀú»ê¼ÒÁõ
  • fetal head
    žƸӸ®
  • fetal infection
    žư¨¿°
  • fetal pole
    ¹è¾Æ±Ø
  • fetal death rate
    žƻç¸Á·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žÆÇ÷»ö¼Ò
  • persistent fetal hemoglobin
    Áö¼ÓžÆÇ÷»ö¼Ò
  • abnormal hemoglobin
    ÀÌ»óÇ÷»ö¼Ò
  • adult hemoglobin
    ¼ºÀÎÇ÷»ö¼Ò
  • carbon monoxide hemoglobin test
    ÀÏ»êȭź¼ÒÇì¸ð±Û·Îºó°Ë»ç
  • hemoglobin absorption curve
    Ç÷»ö¼ÒÈí¼ö°î¼±
  • mean corpuscular hemoglobin concentration
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ
  • denatured hemoglobin
    º¯¼ºÇ÷»ö¼Ò
  • hemoglobin disease
    Çì¸ð±Û·Îºóº´, Ç÷»ö¼Òº´
  • hemoglobin encapsulation
    Ç÷»ö¼ÒÇdz¶
  • fast hemoglobin
    ±Þ¼ÓÇ÷»ö¼Ò
  • hemoglobin
    Ç÷»ö¼Ò
  • hemoglobin test
    Ç÷»ö¼Ò°Ë»ç, Çì¸ð±Û·Îºó°Ë»ç
  • labile hemoglobin
    ºÒ¾ÈÁ¤Ç÷»ö¼Ò
  • mean corpuscular hemoglobin
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistence of fetal form (lobated kidney)
    žÆÇüÅÂÁ¸¼Ó (ºÐ¿±ÄáÆÏ)
  • F hemoglobin fetal
    žƼº(÷Ãä®àõ) Çì¸ð±Û·Îºó
  • Fetal hemoglobin
    žÆÇ÷»ö¼Ò(÷Ãä®úìßäáÈ)
  • hemoglobin, fetal =HbF
    žƼº Çì¸ð±Û·Îºó.
  • hemoglobin, fetal =HbF
    žƼºÇì¸ð±Û·Îºó
  • hereditary persistence of Hb F =HPFH
    À¯Àü¼º žÆÇ÷»ö¼ÒÁö¼Óº´(Áõ)
  • hemoglobin F persistence
    F Çü À¯Á¸Ç÷»ö¼Ò
  • persistence of hemoglobin F
    F Ç÷»ö¼ÒÁö¼ÓÁõ(ò¥áÙñø)
  • FECG= fetal electrocardiogram
    ÅÂ¾Æ½É Àüµµ.
  • Fetal circulation
    žƼøÈ¯(÷Ãä®âàü»)
  • Fetal respiration
    žÆÈ£Èí(÷Ãä®û¼ýå)
  • Fetal thyroid-stimulating hormone
    žư©»ó¼±ÀÚ±Ø(÷Ãä®Ë£ßÒàÍí©Ð½)È£¸£¸ó
  • antigen, fetal
    žÆÇ׿ø
  • antigen,fetal
    žƼº(÷Ãä®àõ)
  • antigen,fetal tumor-associated
    žÆÁ¾¾ç °ü·Ã¼º(÷Ãä®ðþåË Î¼Ö¤àõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistence of fetal form (lobated kidney)
    žÆÇüÅÂÁ¸¼Ó (ºÐ¿±ÄáÆÏ)
  • hereditary persistence of Hb F =HPFH
    À¯Àü¼º žÆÇ÷»ö¼ÒÁö¼Óº´(Áõ)
  • hemoglobin F persistence
    F Çü À¯Á¸Ç÷»ö¼Ò
  • persistence of hemoglobin F
    F Ç÷»ö¼ÒÁö¼ÓÁõ(ò¥áÙñø)
  • fetal hemoglobin
    žƼº Çì¸ð±Û·Îºó, žƼº Ç÷»ö¼Ò(÷Ãä®àõúìßäáÈ).
  • hemoglobin, fetal =HbF
    žƼº Çì¸ð±Û·Îºó.
  • hemoglobin, fetal =HbF
    žƼºÇì¸ð±Û·Îºó
  • persistent fetal hemoglobin
  • persistence
    Á¸¼Ó
  • persistence cathod ray tube
    Áö¼Ó¼º À½±Ø¼±°ü (ò¥áÙàõ ëäпàÊη)
  • persistence of aperture (urachal fistula)
    ±¸¸ÛÁ¸¼Ó (¿ä¸·°ü´©Ãâ°ü)
  • persistence of fissure (spina bifida)
    Æ´»õÁ¸¼Ó (ôÃß»À°¥¸²Áõ)
  • persistence of foramen ovale
    ³­¿ø°ø°³Á¸ (Õ°ê­ÍîËÒðí).
  • persistence of foramen ovale
    ³­¿ø°ø°³Á¸(Õ°ê­ÍîËÒðí)
  • persistence of hyaloid artery
    À¯¸®Ã¼µ¿¸ÆÁ¸¼Ó
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fetal inclusion
    ºÀÀÔžÆ
    [¿¾ ¿ë¾î] ºÀÀÔ±âÇüžÆ
  • Vitamin deficiency (Fetal osteodystrophy)
    ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
    [¿¾ ¿ë¾î] ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
  • Fetal period
    žƱâ
    [¿¾ ¿ë¾î] žƱâ
  • Defect of fetal membrane
    žƸ·°áÇÔ
    [¿¾ ¿ë¾î] Ÿ·°áÇÔ
  • Fetal part
    žƺκÐ
    [¿¾ ¿ë¾î] žƺÎ
  • Fetal parts
    žƺκÐ
    [¿¾ ¿ë¾î] žƺÎ
  • Definitive fetal period
    žƿϼº±â
    [¿¾ ¿ë¾î] žƿϼº±â
  • Fetal cotyledon
    žÆÂÊŹݿ±
    [¿¾ ¿ë¾î] žÆÃøÅ¹ݿ±
  • Initial fetal period
    žÆÃʱâ
    [¿¾ ¿ë¾î] žÆÀü±â
  • Fetal lung
    žÆÇãÆÄ
    [¿¾ ¿ë¾î] ÅÂ¾ÆÆó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žÆ(÷Ãä®) È÷¸ð±Û·Îºó
  • hereditary code
    À¯Àü ºÎÈ£(ë¶îîݬûÜ)
  • hereditary material
    À¯Àü ¹°Áú(ë¶îîÚªòõ)
  • abnormal hemoglobin
    ÀÌ»óÇ÷»ö¼Ò (ì¶ßÈúìßäáÈ)
  • carbon monoxide hemoglobin
    ÀÏ»êȭź¼Ò(ìéß«ûù÷©áÈ) Çì¸ð±Û·Îºó
  • fast hemoglobin
    ºü¸¥ È÷¸ð±Û·Îºó
  • hemoglobin
    È÷¸ð±Û·Îºó
  • hemoglobin switching
    È÷¸ð±Û·Îºó ¹Ù²Ù±â
  • hemoglobin variant
    È÷¸ð±Û·Îºó º¯ÀÌü(ܨì¶ô÷)
  • hybrid hemoglobin
    Æ¢±âÈ÷¸ð±Û·Îºó
  • sickle cell hemoglobin
    ³´¼¼Æ÷(á¬øà)È÷¸ð±Û·Îºó
  • slow hemoglobin
    ¿Ï¼Ó(èÐáÜ) È÷¸ð±Û·Îºó
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žƼºÇì¸ð±Û·Îºó, žƼºÇ÷»ö¼Ò
  • hemoglobin
    Çì¸ð±Û·Îºó, Ç÷»ö¼Ò
  • persistence
    À¯Á¸, Á¸¼Ó
  • persistence of foramen ovale
    ³­¿ø°ø°³Á¸
  • hereditary
    À¯Àü¼ºÀÇ
  • hereditary craniofacial dysostosis
    À¯Àü¼ºµÎ°³¾È¸éÀ̰ñÁõ
  • hereditary disease
    À¯Àüº´
  • hereditary ectodermal polydysplasia
    À¯Àü¼º¿Ü¹è¿±¼º´Ù¹ßÀÌÇü¼ºÁõ
  • hereditary hemorrhagic telangiectasia
    À¯Àü¼ºÃâÇ÷¼º¸ð¼¼Ç÷°üÈ®Àå
  • fetal
    žÆÀÇ, ų»ÀÇ
  • fetal circulation
    žƼøÈ¯, žÆÇ÷Çà
  • fetal death
    žƻç¸Á
  • fetal distress syndrome
    žưï¶õÁõÈıº
  • fetal position
    ÅÂÀ§
  • fetal sac
    ų¶
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HPFH hereditary persistence of fetal hemoglobin
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
HPAFT hereditary persistence of alfa-fetoprotein
HbF fetal hemoglobin, hemoglobin F
N-P need-persistence
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HPFH Hereditary Persistence of Fetal Hemoglobin
DCLHb Diaspirin Cross-Linked Hemoglobin
GHb Glycosylated Hemoglobin
HbA1C Hemoglobin A1C
Hb A2 Hemoglobin A2
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fetal hemoglobin
    žƼº Çì¸ð±Û·Îºó
  • persistence
    À¯Á¸, Á¸¼Ó
  • persistence time
    Áö¼Ó ½Ã°£
  • adult hemoglobin
    ¼ºÀÎÇü Çì¸ð±Û·Îºó
  • hemoglobin
    Ç÷»ö¼Ò, Çì¸ð±Û·Îºó
    1. 4°³ÀÇ Çð°ú ±Û·Îºó ´Ü¹éÁú·Î ±¸¼ºµÈ´Ù. 2. ö °áÇÕüÀÎ ÇðÀÌ »ê¼Ò¿Í °áÇÕÇÏ¿© Ç÷¾×ÀÇ »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â ÀÛ¿ëÀ» ÇÏ¸ç ±× ¿Ü¿¡ ź»ê°¡½º ¿î¹Ý°ú »ê, ¿°±â ÆòÇüÀ» À¯ÁöÇÑ´Ù. 3. Ç÷¾× 100§¢´ç ¾à 15§·ÀÇ Ç÷»ö¼Ò¸¦ ÇÔÀ¯Çϰí ÀÖ´Ù. 4. È­ÇÐÀûÀ¸·Î ÀûÇ÷±¸¸¦ ÀÌ·ç°í ÀÖ´Â ÁÖ¿ä ¹°Áú·Î, ÁöÁú°ú ´Ü¹éÁúÀÇ º¹ÇÕü·Î ÀûÇ÷±¸ÀÇ »ö±òÀ» ³ªÅ¸³»´Â ÁÖµÈ ¹°ÁúÀÌ°í ºÎºÐÀûÀ¸·Î ÀûÇ÷±¸ÀÇ ÇüŸ¦ °áÁ¤Áþ±âµµ ÇÑ´Ù.
  • hemoglobin crystal
    Çì¸ð±Û·Îºó °áÁ¤, Ç÷»ö¼Ò °áÁ¤
  • mean corpuscular hemoglobin
    ÀûÇ÷±¸ÀÇ Æò±Õ Ç÷»ö¼Ò·®
    MCH´Â ÀûÇ÷±¸ ÇÑ °³ ÇÑ °³°¡ °¡Áö´Â Ç÷»ö¼Ò·®ÀÇ Æò±ÕÄ¡¸¦ ¥ì¥ìg¶Ç´Â ¥ã¥ã·Î Ç¥½ÃÇÑ °Í.
  • mean corpuscular hemoglobin concentration
    ÀûÇ÷±¸ÀÇ Ç÷»ö¼Ò Æò±Õ ³óµµ, Æò±Õ ÀûÇ÷±¸ Ç÷»ö¼Ò ³óµµ
    MCHC´Â ÇÑ °³ ÇÑ °³ÀÇ ÀûÇ÷±¸°¡ °¡Áö´Â Ç÷»ö¼Ò ³óµµÀÇ Æò±ÕÀ» %·Î Ç¥½ÃÇÑ °Í.
  • oxygenated hemoglobin
    »êÈ­ Çì¸ð±Û·Îºó, »ê¼Ò °áÇÕ Çì¸ð±Û·Îºó
  • plasma hemoglobin
    Ç÷Àå Çì¸ð±Û·Îºó, Ç÷Àå Ç÷¾×¼Ò
  • abnormal fetal presentation
    ÀÌ»ó ÅÂÀ§
    žÆÀÇ À§Ä¡°¡ ºñÁ¤»óÀûÀÎ °Í.
  • fetal alcohol
    ÅÂ¾Æ ¾ËÄÝ
  • fetal antigen
    ÅÂ¾Æ Ç׿ø
    Á¾¾ç °ü·Ã Ç׿øÀÇ ÀÏÁ¾, Å»ý±â Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö¸¸, Á¤»óÀûÀÎ ºÐÈ­¸¦ ¹âÀº Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö ¾Ê°Å³ª ±ØÈ÷ ¹Ì·® Á¸ÀçÇϰųª ÇÑ´Ù.
  • fetal cartilage
    ų» ¿¬°ñ
  • fetal cretinism
    ÅÂ¾Æ °©»ó¼± ±â´É ÀúÇÏÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hereditary persistence of foetal haemoglobin <haematology> Hereditary persistence of foetal haemoglobin is a genetic condition where adult types of haemoglobin fail to develop and the types of haemoglobin the individual had as a foetus remains present well past the point when they would normally have stopped being produced.
(09 Oct 1997)
hemoglobin <cell biology, haematology> Four subunit globular oxygen carrying protein of the erythrocytes of vertebrates and some invertebrates.
It is a conjugated protein containing four haem groups and globin. There are two alpha and two beta chains (very similar to myoglobin) in adult humans, the haem moiety (an iron containing substituted porphyrin) is firmly held in a nonpolar crevice in each peptide chain.
There are four globin polypeptide chains, designated alpha, beta, gamma, delta in the adult. Each is composed of several hundred amino acids.
(08 Mar 2000)
fetal Of or pertaining to a foetus, pertaining to in utero development after the embryonic period.
(18 Nov 1997)
persistence 1. The tendency of a cell to continue moving in one direction: an internal bias on the random walk behaviour that cells exhibit in isotropic environments.
2. Of viruses that persist in a cell population, animal, plant or population for long periods often in a nonreplicating form, by such strategies as integration into host DNA, immunological suppression or mutation into forms with slow replication.
(18 Nov 1997)
Albright's hereditary osteodystrophy An inherited form of hyperparathyroidism associated with ectopic calcification and ossification and skeletal defects, notably the small fourth metacarpals, but intelligence is normal. There are dominant, recessive and X-linked forms.
See: pseudohypoparathyroidism.
Synonym: Albright's syndrome.
(05 Mar 2000)
angioedema, hereditary A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioneurotic oedema.
(12 Dec 1998)
angioneurotic oedema, hereditary A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioedema.
(12 Dec 1998)
canine hereditary blindness An autosomal dominant condition seen in dogs of the collie and several other breeds.
(05 Mar 2000)
colourectal neoplasms, hereditary nonpolyposis A syndrome characterised by autosomal dominant inheritance, a low mean age (41 years) for occurrence of colon cancer, and a marked increase in the proportion of tumours in the proximal colon.
(12 Dec 1998)
corneal dystrophies, hereditary Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect.
(12 Dec 1998)
hereditary <genetics> Transferred via genes from parent to child.
(16 Dec 1997)
hereditary amyloidosis <neurology> A disorder in which various peripheral nerves are infiltrated with amyloid and their functions disturbed, an abnormal prealbumin is also formed and is present in the blood; characteristically, it begins during mid-life and is found largely in persons of Portuguese descent. Other rare clinical types occur.
Inheritance: autosomal dominant.
Synonym: familial amyloidosis, hereditary amyloidosis.
(05 Mar 2000)
hereditary angioedema A genetic form of angioedema. (angioedema is also referred to as quinke's disease.) persons with it are born lacking an inhibitor protein (called c1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of c1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioneurotic oedema.
(12 Dec 1998)
hereditary angioneurotic oedema A genetic form of angioedema. (angioedema is also referred to as quinke's disease.) persons with it are born lacking an inhibitor protein (called c1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of c1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioedema.
(12 Dec 1998)
hereditary angio oedema <biochemistry> Condition in which there seems to be uncontrolled production of C2 kinin because of a deficiency in C1 inhibitor levels.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žƼº Ç÷»ö¼Ò;žƼº Çì¸ð±Û·Îºó
  • persistence
    Áö¼Ó
  • hemoglobin
    Çì¸ð±Û·Îºó;Ç÷»ö¼Ò
  • persistence
    °íÁý;Áö¼Ó¼º
  • hereditary
    À¯Àü¼ºÀÇ; ¼¼½ÀÀÇ
  • fetal
    žÆÀÇ
  • fetal position
    žÆÇü ÀÚ¼¼
  • hereditary
    À¯ÀüÀÇ;¼¼½ÀÀÇ;´ë´ëÀÇ
  • hereditary peer
    ¼¼½À ±ÍÁ·
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á